TOP STORY

Benzodiazepines may increase risk of CAP, mortality

Benzodiazepines, which have been associated with an increased incidence of infections in the critically ill, also may increase the risk of community-acquired pneumonia (CAP) and mortality following pneumonia, according to a recent report published in Thorax. » More

Continuing Education

New CPE Series: December activity available now

Welcome to the fourth activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The December activity will cover insulin therapy for diabetes care management.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

TODAY'S HEADLINES

Aspirin resistance is rare

Pharmacological resistance to aspirin is rare. Researchers at the University of Pennsylvania in Philadelphia said they could not identify one case of true drug resistance, according to the study published online Dec. 4 in the journal Circulation. » More

Adjunct L-methylfolate may help depressive patients

Augmentation therapy with L-methylfolate may benefit patients who have been diagnosed with major depressive disorder and have had a partial or no response to SSRIs. » More

New drug approval for adults with CML, Ph+ ALL

Following priority review, FDA approved ponatinib (Iclusig, ARIAD Pharmaceuticals) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
» More

TAKE OUR SURVEY

Are you a member of any LinkedIn pharmacy groups?

- Yes
- No

Click Here to let us know.

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out too

• Searching for first e.p.t. test from 1977

• California Medi-Cal rates can be cut

• Men may benefit from osteoporosis drug

• MTM reduces hospital readmissions

Voices

Anticoagulation Update

JP at Large: Loaded doesn't kill you

View from the Zoo: Goal of improved health may fall short despite increased pharmacy workload

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events